IQVIA's Suspicious Order Monitoring (SOM) Services help pharmaceutical distributors and healthcare organizations comply with DEA regulations by combining advanced analytics, artificial intelligence, and expert regulatory guidance to detect and investigate suspicious controlled substance orders. Built with input from former DEA investigators and statistical experts, the solution uses machine learning, predictive analytics, Know Your Customer processes, and customizable algorithms to identify abnormal ordering patterns while accelerating the release of legitimate orders. The cloud-hosted SOM platform simplifies documentation, reporting, customer due diligence, and investigation workflows through AI-generated analysis, natural language queries, and centralized case management. By reducing adm

Join for free to read